Abstract
Protein-energy wasting (PEW) is common among patients undergoing maintenance dialysis, and many signs of PEW can be improved with nutrition support therapy. Early and regular nutrition counseling by registered dietitian (or international equivalent) is essential for the prevention and treatment of PEW in maintenance dialysis patients. When nutrition counseling alone is unable to bridge the gap between protein-energy intake and the target requirements, oral nutritional supplements (ONS) should be prescribed to improve nutritional status. When maintenance dialysis patients with PEW are unable to meet protein and energy requirements with nutrition counseling and ONS, enteral tube feeding should be considered. Intradialytic parenteral nutrition (IDPN) should only be used as supplemental nutrition in hemodialysis patients with PEW, and adequate spontaneous protein and energy intakes are required to compensate for the difference between those provided by IDPN and the target requirements. Intradialytic amino acid therapy remains a viable option for protein-energy wasted peritoneal dialysis patients with insufficient dietary intake, as well as those with tolerance, compliance, and suitability issues of oral intake and other forms of enteral supplementation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar-Zadeh K, Kaysen G, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013;23(2):77–90.
Kovesdy CP, Kopple JD, Kalantar-Zadeh K. Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy. Am J Clin Nutr. 2013;97(6):1163–77.
Lodebo BT, Shah A, Kopple JD. Is it important to prevent and treat protein-energy wasting in chronic kidney disease and chronic dialysis patients? J Ren Nutr. 2018;28(6):369–79.
Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73(4):391–8.
Carrero JJ, Thomas F, Nagy K, Arogundade F, Avesani CM, Chan M, et al. Global prevalence of protein-energy wasting in kidney disease: ameta-analysis of contemporary observational studies from the International Society of Renal Nutrition and Metabolism. J Ren Nutr. 2018;28(6):380–92.
Chertow GM, Johansen KL, Lew N, Lazarus JM, Lowrie EG. Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int. 2000;57(3):1176–81.
den Hoedt CH, Bots ML, Grooteman MP, van der Weerd NC, Penne EL, Mazairac AH, et al. Clinical predictors of decline in nutritional parameters over time in ESRD. Clin J Am Soc Nephrol. 2014;9(2):318–25.
Avram MM, Mittman N, Fein PA, Agahiu S, Hartman W, Chattopadhyay N, et al. Dialysis vintage, body composition, and survival in peritoneal dialysis patients. Adv Perit Dial. 2012;28:144–7.
Sabatino A, Regolisti G, Karupaiah T, Sahathevan S, Sadu Singh BK, Khor BH, et al. Protein-energy wasting and nutritional supplementation in patients with end-stage renal disease on hemodialysis. Clin Nutr. 2017;36(3):663–71.
Ikizler TA, Cano NJ, Franch H, Fouque D, Himmelfarb J, Kalantar-Zadeh K, et al. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int. 2013;84(6):1096–107.
Cano NJ. Chapter 39: Oral and enteral supplements in kidney disease and kidney failure. In: Nutritional management of renal disease. Amsterdam: Elsevier; 2013. p. 659–72.
Lindholm B, Wang T, Heimburger O, Bergstrom J. Influence of different treatments and schedules on the factors conditioning the nutritional status in dialysis patients. Nephrol Dial Transplant. 1998;13(Suppl 6):66–73.
Laville M, Fouque D. Nutritional aspects in hemodialysis. Kidney Int. 2000;58:S133–S9.
Velloso MS, Otoni A, de Paula SA, de Castro WV, Pinto SW, Marinho MA, et al. Peritoneal dialysis and inflammation. Clinica chimica acta. Int JClin Chem. 2014;430:109–14.
Cano N, Fiaccadori E, Tesinsky P, Toigo G, Druml W, Kuhlmann M, et al. ESPEN guidelines on enteral nutrition: adult renal failure. Clin Nutr. 2006;25(2):295–310.
Ikizler TA, Burrowes J, Byham-Gray L, Campbell K, Carrero JJ, Chan W, et al. KDOQI Nutrition in CKD Guideline Work Group. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am J Kidney Dis. 2020; in press.
Fouque D, Vennegoor M, ter Wee P, Wanner C, Basci A, Canaud B, et al. EBPG guideline on nutrition. Nephrol Dial Transplant. 2007;22(Suppl 2):ii45–87.
Dombros N, Dratwa M, Feriani M, Gokal R, Heimburger O, Krediet R, et al. European best practice guidelines for peritoneal dialysis. 8 Nutrition in peritoneal dialysis. Nephrol Dial Transplant. 2005;20(Suppl 9):ix28–33.
Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, et al. Protein losses during peritoneal dialysis. Kidney Int. 1981;19(4):593–602.
Shah A, Bross R, Shapiro BB, Morrison G, Kopple JD. Dietary energy requirements in relatively healthy maintenance hemodialysis patients estimated from long-term metabolic studies. Am J Clin Nutr. 2016;103(3):757–65.
Leon JB, Majerle AD, Soinski JA, Kushner I, Ohri-Vachaspati P, Sehgal AR. Can a nutrition intervention improve albumin levels among hemodialysis patients? A pilot study. J Ren Nutr. 2001;11(1):9–15.
Prasad N, Gupta A, Sinha A, Sharma RK, Kumar A, Kumar R. Changes in nutritional status on follow-up of an incident cohort of continuous ambulatory peritoneal dialysis patients. J Ren Nutr. 2008;18(2):195–201.
Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr. 2008;88(6):1511–8.
Cupisti A, Kalantar-Zadeh K. Management of natural and added dietary phosphorus burden in kidney disease. Semin Nephrol. 2013;33(2):180–90.
Moe SM, Zidehsarai MP, Chambers MA, Jackman LA, Radcliffe JS, Trevino LL, et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(2):257–64.
Chen X, Wei G, Jalili T, Metos J, Giri A, Cho ME, et al. The associations of plant protein intake with all-cause mortality in CKD. Am J Kidney Dis. 2016;67(3):423–30.
D’Alessandro C, Piccoli GB, Cupisti A. The “phosphorus pyramid”: a visual tool for dietary phosphate management in dialysis and CKD patients. BMC Nephrol. 2015;16:9.
Cano NJ, Aparicio M, Brunori G, Carrero JJ, Cianciaruso B, Fiaccadori E, et al. ESPEN guidelines on parenteral nutrition: adult renal failure. Clin Nutr. 2009;28(4):401–14.
Veeneman JM, Kingma HA, Boer TS, Stellaard F, De Jong PE, Reijngoud DJ, et al. Protein intake during hemodialysis maintains a positive whole body protein balance in chronic hemodialysis patients. Am J Physiol Endocrinol Metab. 2003;284(5):E954–65.
Pupim LB, Majchrzak KM, Flakoll PJ, Ikizler TA. Intradialytic oral nutrition improves protein homeostasis in chronic hemodialysis patients with deranged nutritional status. J Am Soc Nephrol. 2006;17(11):3149–57.
Calegari A, Barros EG, Veronese FV, Thome FS. Malnourished patients on hemodialysis improve after receiving a nutritional intervention. J Bras Nefrol. 2011;33(4):394–401.
Wilson B, Fernandez-Madrid A, Hayes A, Hermann K, Smith J, Wassell A. Comparison of the effects of two early intervention strategies on the health outcomes of malnourished hemodialysis patients. J Ren Nutr. 2001;11(3):166–71.
Fouque D, McKenzie J, de Mutsert R, Azar R, Teta D, Plauth M, et al. Use of a renal-specific oral supplement by haemodialysis patients with low protein intake does not increase the need for phosphate binders and may prevent a decline in nutritional status and quality of life. Nephrol Dial Transplant. 2008;23(9):2902–10.
Hung SC, Tarng DC. Adiposity and insulin resistance in nondiabetic hemodialysis patients: effects of high energy supplementation. Am J Clin Nutr. 2009;90(1):64–9.
Cano NJ, Fouque D, Roth H, Aparicio M, Azar R, Canaud B, et al. Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. J Am Soc Nephrol. 2007;18(9):2583–91.
Hiroshige K, Sonta T, Suda T, Kanegae K, Ohtani A. Oral supplementation of branched-chain amino acid improves nutritional status in elderly patients on chronic haemodialysis. Nephrol Dial Transplant. 2001;16(9):1856–62.
Bolasco P, Caria S, Cupisti A, Secci R, Saverio DF. A novel amino acids oral supplementation in hemodialysis patients: a pilot study. Ren Fail. 2011;33(1):1–5.
Tomayko EJ, Kistler BM, Fitschen PJ, Wilund KR. Intradialytic protein supplementation reduces inflammation and improves physical function in maintenance hemodialysis patients. J Ren Nutr. 2015;25(3):276–83.
Allman MA, Stewart PM, Tiller DJ, Horvath JS, Duggin GG, Truswell AS. Energy supplementation and the nutritional status of hemodialysis patients. Am J Clin Nutr. 1990;51(4):558–62.
Moretti HD, Johnson AM, Keeling-Hathaway TJ. Effects of protein supplementation in chronic hemodialysis and peritoneal dialysis patients. J Ren Nutr. 2009;19(4):298–303.
Cheu C, Pearson J, Dahlerus C, Lantz B, Chowdhury T, Sauer PF, et al. Association between oral nutritional supplementation and clinical outcomes among patients with ESRD. Clin J Am Soc Nephrol. 2013;8(1):100–7.
Scott MK, Shah NA, Vilay AM, Thomas J 3rd, Kraus MA, Mueller BA. Effects of peridialytic oral supplements on nutritional status and quality of life in chronic hemodialysis patients. J Ren Nutr. 2009;19(2):145–52.
Sezer S, Bal Z, Tutal E, Uyar ME, Acar NO. Long-term oral nutrition supplementation improves outcomes in malnourished patients with chronic kidney disease on hemodialysis. JPEN J Parenter Enteral Nutr. 2014;38(8):960–5.
Teixido-Planas J, Ortiz A, Coronel F, Montenegro J, Lopez-Menchero R, Ortiz R, et al. Oral protein-energy supplements in peritoneal dialysis: a multicenter study. Perit Dial Int. 2005;25(2):163–72.
Gonzalez-Espinoza L, Gutierrez-Chavez J, del Campo FM, Martinez-Ramirez HR, Cortes-Sanabria L, Rojas-Campos E, et al. Randomized, open label, controlled clinical trial of oral administration of an egg albumin-based protein supplement to patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 2005;25(2):173–80.
Lacson E Jr, Wang W, Zebrowski B, Wingard R, Hakim RM. Outcomes associated with intradialytic oral nutritional supplements in patients undergoing maintenance hemodialysis: a quality improvement report. Am J Kidney Dis. 2012;60(4):591–600.
Ricanati ES, Tserng KY, Kalhan SC. Glucose metabolism in chronic renal failure: adaptive responses to continuous glucose infusion. Kidney Int Suppl. 1983;16:S121–7.
Schneeweiss B, Graninger W, Stockenhuber F, Druml W, Ferenci P, Eichinger S, et al. Energy metabolism in acute and chronic renal failure. Am J Clin Nutr. 1990;52(4):596–601.
Kalantar-Zadeh K, Ikizler TA. Let them eat during dialysis: an overlooked opportunity to improve outcomes in maintenance hemodialysis patients. J Ren Nutr. 2013;23(3):157–63.
Kistler BM, Benner D, Burrowes JD, Campbell KL, Fouque D, Garibotto G, et al. Eating during hemodialysis treatment: aconsensus statement from the International Society of Renal Nutrition and Metabolism. J Ren Nutr. 2018;28(1):4–12.
Choi MS, Kistler B, Wiese GN, Stremke ER, Wright AJ, Moorthi RN, et al. Pilot study of the effects of high-protein meals during hemodialysis on intradialytic hypotension in patients undergoing maintenance hemodialysis. J Ren Nutr. 2019;29(2):102–11.
Cano NJM, Heng A-E. Nutritional problems in adult patients with stage 5 chronic kidney disease on dialysis (both haemodialysis and peritoneal dialysis). NDT Plus. 2009;3(2):109–17.
Patel MG, Raftery MJ. Successful percutaneous endoscopic gastrostomy feeding in continuous ambulatory peritoneal dialysis. J Ren Nutr. 1997;7(4):208–11.
Fein PA, Madane SJ, Jorden A, Babu K, Mushnick R, Avram MM, et al. Outcome of percutaneous endoscopic gastrostomy feeding in patients on peritoneal dialysis. Adv Perit Dial. 2001;17:148–52.
Paudel K, Fan SL. Successful use of continuous ambulatory peritoneal dialysis in 2 adults with a gastrostomy. Am J Kidney Dis. 2014;64(2):316–7.
Rubin J. Nutritional support during peritoneal dialysis-related peritonitis. Am J Kidney Dis. 1990;15(6):551–5.
de Freitas D, Jordaan A, Williams R, Alderdice J, Curwell J, Hurst H, et al. Nutritional management of patients undergoing surgery following diagnosis with encapsulating peritoneal sclerosis. Perit Dial Int. 2008;28(3):271–6.
Sayce HA, Rowe PA, McGonigle RJS. Percutaneous endoscopic gastrostomy feeding in haemodialysis out-patients. J Hum Nutr Diet. 2000;13(5):333–41.
Holley JL, Kirk J. Enteral tube feeding in a cohort of chronic hemodialysis patients. J Ren Nutr. 2002;12(3):177–82.
Brown RO, Compher C. A.S.P.E.N. clinical guidelines: nutrition support in adult acute and chronic renal failure. JPEN J Parenter Enteral Nutr. 2010;34(4):366–77.
Sabatino A, Regolisti G, Antonucci E, Cabassi A, Morabito S, Fiaccadori E. Intradialytic parenteral nutrition in end-stage renal disease: practical aspects, indications and limits. J Nephrol. 2014;27(4):377–83.
Hoffer LJ. How much protein do parenteral amino acid mixtures provide? Am J Clin Nutr. 2011;94(6):1396–8.
Pupim LB, Flakoll PJ, Brouillette JR, Levenhagen DK, Hakim RM, Ikizler TA. Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J Clin Invest. 2002;110(4):483–92.
Pupim LB, Flakoll PJ, Ikizler TA. Nutritional supplementation acutely increases albumin fractional synthetic rate in chronic hemodialysis patients. J Am Soc Nephrol. 2004;15(7):1920–6.
Pupim LB, Flakoll PJ, Levenhagen DK, Ikizler TA. Exercise augments the acute anabolic effects of intradialytic parenteral nutrition in chronic hemodialysis patients. Am J Physiol Endocrinol Metab. 2004;286(4):E589–97.
Ikizler TA, Pupim LB, Brouillette JR, Levenhagen DK, Farmer K, Hakim RM, et al. Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. Am J Physiol Endocrinol Metab. 2002;282(1):E107–16.
Guarnieri G, Faccini L, Lipartiti T, Ranieri F, Spangaro F, Giuntini D, et al. Simple methods for nutritional assessment in hemodialyzed patients. Am J Clin Nutr. 1980;33(7):1598–607.
Cano N, Labastie-Coeyrehourq J, Lacombe P, Stroumza P, di Costanzo-Dufetel J, Durbec JP, et al. Perdialytic parenteral nutrition with lipids and amino acids in malnourished hemodialysis patients. Am J Clin Nutr. 1990;52(4):726–30.
Navarro JF, Mora C, Leon C, Martin-Del Rio R, Macia ML, Gallego E, et al. Amino acid losses during hemodialysis with polyacrylonitrile membranes: effect of intradialytic amino acid supplementation on plasma amino acid concentrations and nutritional variables in nondiabetic patients. Am J Clin Nutr. 2000;71(3):765–73.
Cano NJ, Saingra Y, Dupuy AM, Lorec-Penet AM, Portugal H, Lairon D, et al. Intradialytic parenteral nutrition: comparison of olive oil versus soybean oil-based lipid emulsions. Br J Nutr. 2006;95(1):152–9.
Marsen TA, Beer J, Mann H. Intradialytic parenteral nutrition in maintenance hemodialysis patients suffering from protein-energy wasting. Results of a multicenter, open, prospective, randomized trial. Clin Nutr. 2017;36(1):107–17.
Hiroshige K, Iwamoto M, Kabashima N, Mutoh Y, Yuu K, Ohtani A. Prolonged use of intradialysis parenteral nutrition in elderly malnourished chronic haemodialysis patients. Nephrol Dial Transplant. 1998;13(8):2081–7.
Toigo G, Situlin R, Tamaro G, Del Bianco A, Giuliani V, Dardi F, et al. Effect of intravenous supplementation of a new essential amino acid formulation in hemodialysis patients. Kidney Int Suppl. 1989;27:S278–81.
Cranford W. Cost effectiveness of IDPN therapy measured by hospitalizations and length of stay. Nephrol News Issues. 1998;12(9):33–5, 7–9.
Gosmanov AR, Umpierrez GE. Management of hyperglycemia during enteral and parenteral nutrition therapy. Curr Diab Rep. 2013;13(1):155–62.
Moore E. Challenges of nutrition intervention for malnourished dialysis patients. J Infus Nurs. 2008;31(6):361–6.
Sarav M, Friedman AN. Use of intradialytic parenteral nutrition in patients undergoing hemodialysis. Nutr Clin Pract. 2018;33(6):767–71.
Kopple JD, Bernard D, Messana J, Swartz R, Bergstrom J, Lindholm B, et al. Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int. 1995;47(4):1148–57.
Li FK, Chan LY, Woo JC, Ho SK, Lo WK, Lai KN, et al. A 3-year, prospective, randomized, controlled study on amino acid dialysate in patients on CAPD. Am J Kidney Dis. 2003;42(1):173–83.
Jones M, Hagen T, Boyle CA, Vonesh E, Hamburger R, Charytan C, et al. Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study. Am J Kidney Dis. 1998;32(5):761–9.
Misra M, Reaveley DA, Ashworth J, Muller B, Seed M, Brown EA. Six-month prospective cross-over study to determine the effects of 1.1% amino acid dialysate on lipid metabolism in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1997;17(3):279–86.
Tjiong HL, Swart R, Van den Berg JW, Fieren MW. Dialysate as food as an option for automated peritoneal dialysis. NDT Plus. 2008;1(Suppl 4):iv36–40.
Tjiong HL, van den Berg JW, Wattimena JL, Rietveld T, van Dijk LJ, van der Wiel AM, et al. Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis. J Am Soc Nephrol. 2005;16(5):1486.
Tjiong HL, Rietveld T, Wattimena JL, van den Berg JW, Kahriman D, van der Steen J, et al. Peritoneal dialysis with solutions containing amino acids plus glucose promotes protein synthesis during oral feeding. Clin J Am Soc Nephrol. 2007;2(1):74.
Garibotto G, Sofia A, Canepa A, Saffioti S, Sacco P, Sala M, et al. Acute effects of peritoneal dialysis with dialysates containing dextrose or dextrose and amino acids on muscle protein turnover in patients with chronic renal failure. J Am Soc Nephrol. 2001;12(3):557–67.
Wolfson M, Jones M. Intraperitoneal nutrition. Am J Kidney Dis. 1999;33(1):203–4.
Delarue J, Maingourd C, Objois M, Pinault M, Cohen R, Couet C, et al. Effects of an amino acid dialysate on leucine metabolism in continuous ambulatory peritoneal dialysis patients. Kidney Int. 1999;56(5):1934–43.
Park MS, Choi SR, Song YS, Yoon SY, Lee SY, Han DS. New insight of amino acid-based dialysis solutions. Kidney Int. 2006;70:S110–S4.
Tjiong HL, Swart R, van den Berg JW, Fieren MW. Amino acid-based peritoneal dialysis solutions for malnutrition: new perspectives. Perit Dial Int. 2009;29(4):384–93.
Dombros N, Dratwa M, Feriani M, Gokal R, Heimburger O, Krediet R, et al. European best practice guidelines for peritoneal dialysis. 5 Peritoneal dialysis solutions. Nephrol Dial Transplant. 2005;20(Suppl 9):ix16–20.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Case Study
Case Study
A 51-year-old Caucasian man (Mr. Smith) with a medical history of stage 5 CKD secondary to hypertension and glomerulonephritis presents with progressive decline of kidney function, poor appetite, nausea, lethargy, and decreased urine output. His nutritional assessment parameters are as follows: height = 170 cm; weight = 75.6 kg; BMI = 26.2 kg/m2; 5% unintentional weight loss over the past 3 months; SGA score = 4; serum albumin = 3.4 g/dL; and pedal edema. Peritoneal dialysis is started with the aim of removing excess fluid and uremic toxins, as well as improving nutritional status.
At 3 months after initiating peritoneal dialysis, Mr. Smith is feeling better. His pedal edema is resolving. His uremic symptoms, appetite, and oral intake are improving. His nutritional assessment parameters are as follows: dry body weight = 73.6 kg; BMI = 25.5 kg/m2; serum albumin = 4.0 g/dL; and SGA score = 6. Upon physical examination, Mr. Smith is euvolemic. His total intakes of protein and energy including the calories provided by the peritoneal dialysate are 1.3 g protein/kg/day and 33 kcal/kg/day, respectively.
Having been treated with peritoneal dialysis for 3 years, Mr. Smith is admitted to hospital due to turbid peritoneal effluent accompanied by constant abdominal pain. He had two prior episodes of peritonitis in the past few years. The laboratory findings and bacterial culture of the peritoneal dialysate confirm PD-associated peritonitis. At the same time, Mr. Smith experiences nausea, poor appetite, and reduced food intake. His food record chart indicates an ingestion of approximately 0.6 g protein/kg/day and 24 kcal/kg/day on the first few days of hospital admission.
Mr. Smith is given a 2-week course of intraperitoneal antibiotics upon diagnosis of peritonitis. He is also prescribed a trial of renal-specific ONS, providing an additional 25 g protein and 500 kcal daily. With the completion of the antibiotic therapy and the resolution of the peritonitis, improvements in appetite and oral intake are observed. He is subsequently discharged from the hospital. Upon hospital discharge, his estimated total protein and energy intakes including the use of ONS are 1.2 g/kg/day and 32 kcal/kg/day, respectively. His nutritional assessment parameters are as follows: dry weight = 71.5 kg; BMI = 24.7 kg/m2; 6% unintentional weight loss over the past 3 months; serum albumin = 3.4 g/dL; and SGA score = 4. In view of recurrent peritonitis, his renal replacement therapy is changed from peritoneal dialysis to hemodialysis.
At 2–3 months after transition to hemodialysis, his nutritional parameters are as follows: dry weight = 76.1 kg; BMI = 26.3 kg/m2; serum albumin = 4.1 g/dL; and SGA score = 6. Upon physical examination, he is euvolemic. His food diary shows an estimated consumption of 1.2 g protein/kg/day and 33 kcal/kg/day excluding the use of ONS.
Over the course of the next few years, he is relatively stable, and receives regular nutrition counseling from a registered dietitian. He is compliant with his hemodialysis regimen and manages to maintain nutritional assessment parameters within acceptable ranges. After 3–4 years on hemodialysis, Mr. Smith is admitted to hospital for 3 weeks with pneumonia. His nutritional assessment parameters immediately post-discharge are as follows: dry weight = 68.8 kg; BMI = 23.8 kg/m2; 9% unintentional weight loss over the past 2 months; temporal wasting indicated by physical examination; serum albumin = 3.2 g/dL; and SGA score = 4. His diet history indicates a spontaneous dietary intake of 0.9 g protein/kg/day and 25 kcal/kg/day.
Over the course of the next 3 months, there is no improvement in Mr. Smith’s nutritional assessment parameters. His nutritional status continues to decline despite liberalization of his diet and the use of ONS. His nutritional assessment parameters are as follows: dry weight = 64.2 kg; BMI = 22.2 kg/m2; unintentional weight loss of 7% over the past 3 months; muscle and fat wasting upon physical examination; serum albumin = 3.1 g/dL; and SGA score = 2. His diet history shows a consumption of 0.7 g protein/kg/day and 19 kcal/kg/day.
Although enteral tube feeding is proposed to Mr. Smith, he is very reluctant to attempt the suggested feeding methods including nasogastric tube feeding and percutaneous endoscopic gastrostomy feeding. With Mr. Smith’s agreement, the multidisciplinary team decides to commence IDPN. At 5 months after starting IDPN, there is only marginal improvement in Mr. Smith’s nutritional assessment parameters, and no improvement is observed for spontaneous dietary protein and energy intakes. IDPN is subsequently discontinued. After further discussion with Mr. Smith, he eventually consents to initiate enteral nutrition via nasogastric tube feeding. Subsequently, there are progressive improvements in spontaneous dietary protein and energy intakes, as well as various nutritional assessment parameters.
Case Questions and Answers
-
1.
Is Mr. Smith presented with PEW upon initiation of peritoneal dialysis?
-
Answer: Yes, PEW can emerge in early CKD, and the risk of PEW increases as CKD progresses. Mr. Smith displays signs of PEW including poor appetite, nausea, 5% weight loss over the past 3 months, moderate PEW on SGA, and mild hypoalbuminemia.
-
2.
Compared to nondialysis-dependent CKD, what are the specific concerns with the recommendations for dietary protein and energy intakes in maintenance peritoneal dialysis?
-
Answer: Compared to nondialysis-dependent CKD, higher protein and energy intakes are recommended by current evidence-based practice guidelines and expert consensus statement, that is, 1.0–1.5 g protein/kg BW/day and 25–35 kcal/kg BW/day. Every effort should be made to remove any unnecessary dietary restrictions. Education on calorie-dense foods and high biological value protein is necessary, as well as ways to improve oral intake.
-
3.
After initiating peritoneal dialysis, should Mr. Smith aim for a dietary energy intake of 25–35 kcal/kg BW/day?
-
Answer: No, Mr. Smith absorbs calories from glucose in the dialysate, and the calories provided by the peritoneal dialysate should be subtracted from 25 to 35 kcal/kg BW/day to derive the target dietary energy intake.
-
4.
Is Mr. Smith presented with PEW at 3 months after the initiation of peritoneal dialysis?
-
Answer: Mr. Smith has no obvious signs of PEW at 3 months after the initiation of peritoneal dialysis. His total protein and energy intakes are within the target requirement ranges, alongside improvements in appetite and oral intake. Although a reduction in body weight is observed, it is likely a resolution of volume overload reflected by euvolemia upon physical examination. Mr. Smith is no longer hypoalbuminemic, and his SGA score is not suggestive of PEW.
-
5.
On the first day of his peritonitis-associated hospital admission, he was prescribed a renal menu (i.e., a menu that is protein-energy dense and low in electrolytes). Is this menu adequate as a form of nutrition support therapy? If not, what should be the next appropriate step of nutrition support and how would you optimize the outcome?
-
Answer: No, the prescription of a renal menu is insufficient to meet both protein and energy requirements. This is indicated by low protein and energy intakes on the food record chart, alongside reported symptoms of nausea, poor appetite, and reduced food intake. A full nutritional assessment is required, and the use of ONS should be considered as the next appropriate step. ONS should be prescribed based on the patient’s requirements, preference, compliance, and tolerance, as these are important success factors.
-
6.
After his recovery from peritonitis, should he be discharged from the hospital with an ONS prescription?
-
Answer: Yes, although Mr. Smith is meeting both protein and energy requirements, it is derived from both oral diet and the use of ONS. An oral diet alone remains insufficient to attain the requirements. Mr. Smith is displaying signs of PEW including 6% unintentional weight loss over the past 3 months, hypoalbuminemia, and moderate PEW on SGA. Regular nutritional assessment and continuous dietary counseling are essential after the initiation of hemodialysis.
-
7.
Should the use of ONS be discontinued at 2–3 months after transition to hemodialysis?
-
Answer: Yes, the use of ONS should be discontinued, because his nutritional status has improved with no obvious signs of PEW. He is attaining both protein and energy targets without the use of ONS.
-
8.
Mr. Smith was prescribed a trial of renal-specific ONS during the episode of pneumonia-associated hospitalization. Should he continue to take the ONS after hospital discharge?
-
Answer: Yes, ONS should be continued upon hospital discharge, because Mr. Smith is displaying signs of PEW including unintentional weight loss, temporal wasting on physical examination, moderate PEW on SGA, and hypoalbuminemia. His spontaneous dietary protein and energy intakes are insufficient to meet protein and energy requirements, but both intakes are higher than the required minimum for ONS to be effective (e.g., 20–24 kcal/kg/day and 0.8–1.0 g protein/kg/day). Regular monitoring and intensive nutrition counseling are critical during the supplementation period. Implementing changes to the ONS prescription may be necessary to improve Mr. Smith’s adherence and hence the overall effectiveness of ONS.
-
9.
Despite liberalization of his diet and the use of ONS, his nutritional status continues to decline. Is Mr. Smith an ideal candidate for enteral tube feeding ?
-
Answer: Yes, Mr. Smith is an ideal candidate for enteral tube feeding . He is exhibiting severe PEW on SGA, hypoalbuminemia, and unintentional weight loss of 7% over the past 3 months. His spontaneous dietary protein and energy intakes are <0.8 g/kg/day and <20 kcal/kg/day. Continuation of ONS and nutrition counseling are unlikely to achieve the recommended dietary protein and energy requirements. Daily nutrition support is important for Mr. Smith, and enteral nutrition should always be preferable to parenteral nutrition as feeding through the gastrointestinal tract helps to maintain its normal structure and function.
-
10.
Should IDPN be discontinued after a trial period of 5 months?
-
Answer: Yes, most maintenance hemodialysis patients respond to IDPN after 3–6 months of therapy. Lack of improvement after 3–6 months should render a decision to discontinue.
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chan, W. (2020). Nutrition Support in Hemodialysis and Peritoneal Dialysis. In: Burrowes, J., Kovesdy, C., Byham-Gray, L. (eds) Nutrition in Kidney Disease. Nutrition and Health. Humana, Cham. https://doi.org/10.1007/978-3-030-44858-5_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-44858-5_17
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-030-44857-8
Online ISBN: 978-3-030-44858-5
eBook Packages: MedicineMedicine (R0)